Clinical Outcomes and Costs Analyses in Use of Goal Directed Therapy
Not Applicable
Completed
- Conditions
- Postoperative Complications
- Interventions
- Device: Goal Directed Fluid Therapy FloTrac/Vigileo
- First Posted Date
- 2013-11-27
- Last Posted Date
- 2016-04-07
- Lead Sponsor
- Regina Elena Cancer Institute
- Target Recruit Count
- 200
- Registration Number
- NCT01995786
- Locations
- ๐ฎ๐น
Regina Elena CI, Rome, Italy
Sevoflurane Protective Effect on Ischemia Reperfusion Injury in Microvascular Surgery
Not Applicable
Completed
- Conditions
- Microvascular Breast Flap in Plastic Surgery
- Interventions
- First Posted Date
- 2013-10-30
- Last Posted Date
- 2016-04-07
- Lead Sponsor
- Regina Elena Cancer Institute
- Target Recruit Count
- 128
- Registration Number
- NCT01972230
- Locations
- ๐ฎ๐น
Regina Elena Cancer Institute, Rome, RM, Italy
Sevoflurane Protective Effect on Ischemia-reperfusion Injury. Multicenter, Randomized Controlled Trial
Not Applicable
Completed
- Conditions
- Microsurgical Free Flaps
- Interventions
- Drug: Balanced anesthesiaDrug: Total intravenous anesthesia
- First Posted Date
- 2013-07-23
- Last Posted Date
- 2016-04-07
- Lead Sponsor
- Regina Elena Cancer Institute
- Target Recruit Count
- 132
- Registration Number
- NCT01905501
- Locations
- ๐ฎ๐น
Regina Elena CI, Rome, Italy
Goal Directed Therapy (GDT) in Cytoreductive Surgery (CRS) and Hyperthermic Intra Peritoneal Chemotherapy (Hipec)
Not Applicable
Completed
- Conditions
- Primary Peritoneal NeoplasmSecondary Peritoneal Neoplasm
- Interventions
- Drug: Conventional Intravenous Fluid therapyDrug: Goal Directed Intravenous Restrictive Fluid Therapy
- First Posted Date
- 2013-06-21
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- Regina Elena Cancer Institute
- Target Recruit Count
- 80
- Registration Number
- NCT01882920
- Locations
- ๐ฎ๐น
Regina Elena CI, Rome, Italy
Determination of Predictive Genetic Markers of Toxicity After Hypofractionated Radiotherapy in Breast Cancer Patients Post-Conservative Surgery
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2011-03-16
- Last Posted Date
- 2011-03-16
- Lead Sponsor
- Regina Elena Cancer Institute
- Registration Number
- NCT01316328
- Locations
- ๐ฎ๐น
Regina Elena NCI, Rome, Italy
A Study, Comparing a Dose-Titration Regimen of Fulvestrant With the Approved Dosing Regimen in Postmenopausal Patients With Hormone-Responsive Advanced Breast Cancer (ABC)
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2011-07-22
- Lead Sponsor
- Regina Elena Cancer Institute
- Target Recruit Count
- 104
- Registration Number
- NCT00927511
- Locations
- ๐ฎ๐น
Regina Elena Cancer Institute, Rome, RM, Italy
ยฉ Copyright 2025. All Rights Reserved by MedPath